Article
From Prescription to Transcription: Genome Sequence as Drug Target.
Cell - 2 Jul 2015
Guo Cong, D'Ippolito Anthony M, Reddy Timothy E
Abstract excerpt
Personalizing treatments to account for genetically mediated differences in drug responses is an exciting opportunity to improve patient outcomes. In this issue, Soccio et al. reveal new mechanisms by which non-coding variants alter the activity of the anti-diabetic drug rosiglitazone.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
